{
  "Q0": "BRCA1 and BRCA2 (BRCA1/2) gene analysis for hereditary breast and ovarian cancer susceptibility.",
  "Q1": "Yes",
  "Q2": "Yes",
  "Q3": "Yes",
  "Q4": "Yes",
  "Q4a": "Yes",
  "Q4b": [
    "NCCN"
  ],
  "Q5": "Not required",
  "Q6": "No",
  "Q7": "Yes",
  "Q8": "No",
  "Q9": "Yes",
  "Q9a": "No",
  "Q10": "No",
  "Q10a": "Diagnostic",
  "Q11": "Yes",
  "Q12": "No",
  "Q13": "Yes",
  "Q14": "Yes",
  "Q14a": [
    "81162",
    "81163",
    "81164",
    "81212",
    "81215",
    "81216",
    "81217"
  ],
  "Q15": "No",
  "Q16": "Yes",
  "Q17": "The provider must complete and submit the 'Aetna Breast and Ovarian Cancer Susceptibility Gene Testing Prior Authorization Form' along with the laboratory's test requisition form to Aetna for precertification. Documentation of the patient's cancer diagnosis and pertinent medical records must be included. A summary indicating how the test will change the immediate medical care of the member must also be provided. The laboratory should not proceed with testing until confirmation of coverage and precertification is received from Aetna.",
  "match": true
}